Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Medications for Child with Chronic Constipation

소아 변비 치료에서 약물사용

  • Bae, Sun Hwan (Department of Pediatrics, School of Medicine, Konkuk University)
  • 배선환 (건국대학교 의학전문대학원 소아과학교실)
  • Received : 2009.10.31
  • Accepted : 2009.11.06
  • Published : 20091100
Download PDF
⟨ Previous Next ⟩

Abstract

Constipation is one of the most common symptoms that a child visits pediatrician. The general approach to the child with functional constipation includes the following steps; disimpaction, maintenance and withdrawal of medication. There are many drugs which can be applied to children; osmotic agents (lactulose, sorbitol, magnesium hydroxide/citrate, polyethylene glycol with/without electrolytes, sodium phosphate, glycerin), stimulants (senna, bisacodyl, caster oil), lubricant (mineral oil), bulking agent (psyllium, cellulose, glucomannan). At each stage of treatment, one or some of these drug can be applied to the purpose. The author tries to summarize recent studies on drugs for constipation in child, and finally introduces new dugs for constipation which is under investigation.

Keywords

References

  1. Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Evaluation and treatment of constipation in infants and children: recommendations of the north american society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr 2006;43:e1-e13. https://doi.org/10.1097/01.mpg.0000233159.97667.c3
  2. Brady CE 3rd, DiPalma JA, Morawski SG, Santa Ana CA, Fordtran JS. Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solution. Gastroenterology 1986; 90:1914-8.
  3. Dipalma JA, DeRidder PH, Orlando RC, Kolts BE, Clveland MB. A randomzed, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95:446-50. https://doi.org/10.1111/j.1572-0241.2000.01765.x
  4. Bae SH, So HS, Yoon HS, Hwang JS. Efficacy and safety of polyethylene glycol (PEG) with electrolytes for disimpaction in children with chronic functional constipation. J Pediatr Gastroenerol Nutr 2004;39(Suppl 1): S231-2.
  5. Ingebo KB, Heyman MB. Polyethylene glycol-electrolyte solution for intestinal clearance in children with refractory encoporesis. Am J Dis Child 1988;142:340-4.
  6. Schiller LR. Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol 1999;28:11-8. https://doi.org/10.1097/00004836-199901000-00003
  7. Jenkins DJA, Wolever TMS, Leeds AR, et al. Dietary fibres, fibre analogues, and glucose tolerance:importance of viscocity. Br Med J 1978;1:1392-4. https://doi.org/10.1136/bmj.1.6124.1392
  8. Harrington L, Schuh S. Complications of $Fleet{\circledR}$ enema administration and suggested guidelines for use in the pediatric emergency department. Pediatr Emergency Care 1997;13:225-6. https://doi.org/10.1097/00006565-199706000-00014
  9. Sharif F, Crushell E, O'Driscoll K, Bourke B. Liquid paraffin: A reappraisal of its role in the treatment of constipation. Arch Dis Child 2001;85:121-4. https://doi.org/10.1136/adc.85.2.121
  10. Loening-Baucke V. Constipation and encopresis. In: Robert Wyllie, Jeffrey S Hyams. editors. Pediatric gastrointestinal and liver disease. 3rd ed. Elsevier:Saunders Co, 2006:177-91.
  11. Lee JH, Lee R, Bae SH. Efficacy and safety of electrolyte- free polyethylene glycol (PEG) 4000 for disimpaction in children with chronic functional constipation. Korean J Pediatr 2008;51:391-5. https://doi.org/10.3345/kjp.2008.51.4.391
  12. Youssef NN, Peters JM, Henderson W, Shultz-Peters S, Lockhart DK, Lorenzo CD. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 2002;141:410-4. https://doi.org/10.1067/mpd.2002.126603
  13. Tolia V, Lin CH, Elitsur Y. A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children. Aliment Pharmacol Ther 1993;7:523-9.
  14. Loening-Baucke V, Krishna R, Pashankar DS. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 2004;39:536-9. https://doi.org/10.1097/00005176-200411000-00016
  15. Lee SH, Bae SH. Maintenance dose of electrolyte free polyethylene glycol (PEG) 4000 in Korean children with chronic functional constipation. Korean J Pediatr 2007;50: 1212-6. https://doi.org/10.3345/kjp.2007.50.12.1212
  16. Dupont C, Leluyer B, Amar F, Kalach N, Benhamou PH, Mouterde O, Vannerom PY. A dose determination study of polyethylene glycol 4000 in constipated children: Factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr 2006;42:178-85. https://doi.org/10.1097/01.mpg.0000189349.17549.a9
  17. Bae SH. Long-term safety of PEG 4000 in children with chronic functional constipation. Program and Abstract, the 58th Annual Fall Meeting of the Korean Pediatric Society; 2008 Oct 24-25; Seoul. Seoul: The Korean Pediatric Society, 2008:116.
  18. Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002;34:372-7 https://doi.org/10.1097/00005176-200204000-00011
  19. Gremse DA, Hixon J, Crutchfield A. Comparrison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation. Clin pediatr(Phila) 2002;41:225-9. https://doi.org/10.1177/000992280204100405
  20. Loening-Baucke V, Miele E, Staiano A. fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics 2004;113:e259-64. https://doi.org/10.1542/peds.113.3.e259
  21. Bae SH. The effect of water intake on treatment of chronic functional constipation. Program and Abstract, the 56th Annual Fall Meeting of the Korean Pediatric Society; 2008 Oct 20-21; Seoul. Seoul: The Korean Pediatric Society, 2006:105.
  22. Lacy BE, Levy LC. Lubiprostone: a chloride channel activator. J Clin Gastroenterol. 2007;41:345-51. https://doi.org/10.1097/01.mcg.0000225665.68920.df
  23. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008;358:2344-54. https://doi.org/10.1056/NEJMoa0800670
  24. Liem O, Mousa HM, Benninga MA, Di Lorenzo C. Tegaserod use in children: a single-center experience. J Pediatr Gastroenterol Nutr 2008;46:54-8. https://doi.org/10.1097/01.mpg.0000304454.99799.42